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Background
Valid measures of asthma and eczema in epidemiological
studies may be a challenge. Population-based registers
can be useful as they do not rely on recall and allow for
follow-up. Our aim was to ascertain if asthma/eczema
medication is a suitable proxy for asthma/eczema and to
validate register-based asthma diagnoses.
Method
Data were retrieved on all 0-17-year-old individuals with
reported asthma/eczema medication in the Swedish
Prescribed Drug Register (SPDR) and/or an asthma
diagnosis in the National Patient Register (NPR)
between 2005-2009 (N=121,944). Medical records
retrieved from prescribing units, for 2,250 randomly
selected individuals, were reviewed to estimate the pro-
portion of individuals with 1) asthma/eczema medication
in the SPDR who had a doctor diagnosis of asthma/
eczema and/or; 2) fulfilled predefined criteria of asthma
by the Swedish Paediatric Society (positive predictive
value, PPV); 3) an asthma diagnosis in the NPR verified
as asthmatics by predefined criteria.
Results
PPV for asthma medication as a proxy for a doctor diag-
nosis of asthma was 0.68 (95%CI: 0.64-0.72) in pre-school
children (0-4.5 years) and 0.89 (95%CI: 0.85-0.92) in
school-age children (>4.5-17 years). The corresponding
PPV for predefined criteria of asthma was 0.75 (95%CI:
0.70-0.78) and 0.94 (95%CI: 0.91- 0.96) in pre-school chil-
dren and school-age children respectively. Almost all
(99%) of school-age children and 78% of pre-school chil-
dren with an asthma diagnosis in the NPR were verified as
asthmatics. PPV for eczema medication as a proxy for an
eczema diagnosis was estimated to 0.45 (95% CI: 0.38-
0.51) in children 0-17 years.
Conclusion
Asthma medication is the SPDR is a suitable proxy for
asthma in older children; the same approach is insufficient
for eczema. Furthermore, the quality of asthma diagnoses
in the NPR is high. This validation study of two Swedish
registers opens for future large nation-wide studies on
asthma.
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